Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains

Microbiology

Volumn 145, Issue 1, 1999, Pages 221-229

  Somner, Elizabeth A ^a,c   Ogun, Solabomi A ^b   Sinha, Katharine A ^a   Spencer Valero, Lilian M ^b   Lee, Jeong Jin ^a   Harrison, Julia A ^a   Holder, Anthony A ^b   Hormaeche, Carlos E ^a   Khan, C M Anjam ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Conformational epitopes; Malaria; MSP119; Salmonella; Vaccine

Indexed keywords

GLUTATHIONE TRANSFERASE; SALMONELLOSIS VACCINE; TETANUS TOXIN;

ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; FEMALE; IMMUNOFLUORESCENCE; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SALMONELLA; SALMONELLA TYPHIMURIUM;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA; NEGIBACTERIA; PLASMODIUM YOELII; PROTOZOA; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0032919206     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-145-1-221     Document Type: Article

References (35)

1. Aggarwal, A., Kumar, S., Jaffe, R., Hone, D., Gross, M. & Sadoff, J. (1990). Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J Exp Med 172, 1083-1090.
2. Blackman, M. J., Heidrich, H. G., Donachie, S., McBride, J. S. & Holder, A. A. (1990). A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172, 379-382.
3. Blackman, M. J., Ling, I. T., Nicholls, S. C. & Holder, A. A. (1991). Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol 49, 29-34.
4. Blackman, M. J., Scott Finnigan, T., Shai, S. & Holder, A. A. (1994). Antibodies inhibit the protease mediated processing of a malaria merozoite surface protein. J Exp Med 180, 389-393.
5. Brown, A., Hormaeche, C. E., Demarco de Hormaeche, R. A., Dougan, G., Winther, M., Maskall, D. & Stocker, B. A. D. (1987). An attenuated aroA S. typhimurium vaccine elicits humoral and cellular immunity to cloned-beta galactosidase in mice. J Infect Dis 155, 86-92.
6. Burghaus, P. A. & Holder, A. A. (1994). Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol 64, 165-169.
7. Chabalgoity, J. A., Khan, C. M. A., Nash, A. A. & Hormaeche, C. E. (1996). A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from Herpes simplex virus infection. Mol Microbiol 19, 791-801.
8. Chappel, J. A. & Holder, A. A. (1993). Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol Biochem Parasitol 60, 303-312.
9. Chatfield, S. N., Strahan, K., Pickard, D., Charles, I. G., Hormaeche, C. E. & Dougan, G. (1992). Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and AroA in the murine salmonellosis model. Microb Pathog 12, 145-151.
10. Chatfield, S. N., Roberts, M., Dougan, G., Hormaeche, C. & Khan, C. M. A. (1995). The development of oral vaccines against parasitic diseases utilising live attenuated Salmonella. Parasitology 10, S17-S24.
11. Cooper, J. A., Cooper, L. T. & Saul, J. A. (1992). Mapping of the region predominantly recognised by antibodies to the Plasmodium falciparum merozoite surface antigen MSA-1. Mol Biochem Parasitol 51, 301-312.
12. Daly, T. M. & Long, C. A. (1993). A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect Immun 61, 2462-2467.
13. Daly, T. M. & Long, C. A. (1995). Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 155, 236-243.
14. Daly, T. M. & Long, C. A. (1996). Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect Immun 64, 2602-2608.
15. Etlinger, H. M., Caspers, P., Matile, H., Schoenfeld, H. J., Stueber, D. & Takacs, B. (1991). Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun 59, 3498-3503.
16. Flynn, J. L., Weiss, W. R., Norris, K. A., Seifert, H. S., Kumar, S. & So, M. (1990). Generation of a cytotoxic lymphocyte T response using a Salmonella antigen delivery system. Mol Microbiol 4, 2111-2118.
17. Gonzalez, C., Hone, D., Noriega, F. R. & 12 other authors (1994). Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis 169, 927-931.
18. Hoiseth, S. K. & Stocker, B. A. D. (1981). Aromatic dependent Salmonella typhimurium are nonvirulent and effective live vaccines. Nature 291, 238-239.
19. Holder, A. A. & Freeman, R. R. (1984). Characterization of a high molecular weight protective antigen of Plasmodium yoelii. Parasitology 88, 211-219.
20. Hormaeche, C. E. & Khan, C. M. A. (1996). Recombinant bacteria as vaccine carriers of heterologous antigens. In Concepts in Vaccine Development, pp. 327-359. Edited by S. H. E. Kaufmann. Berlin: Walter de Gruyter.
21. Hormaeche, C. E., Khan, C. M. A., Mastroeni, P., Villarreal, B., Dougan, G. & Chatfield, S. N. (1995). Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In Molecular and Clinical Aspects of Vaccine Development, pp. 119-153. Edited by D. Ala'Aldeen & C. E. Hormaeche. Chichester: Wiley.
22. Johnson, K., Charles, I., Dougan, G., Pickard, D., O'Gaora, C., Costa, G., Ali, T., Miller, I. & Hormaeche, C. (1991). The role of a stress-response protein in Salmonella typbimurium virulence. Mol Microbiol 5, 401-407.
23. Khan, C. M. A., Villarreal-Ramos, B., Pierce, R. J. & 7 other authors (1994a). Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. J Immunol 153, 5634-5642.
24. Khan, C. M. A., Villarreal-Ramos, B., Pierce, R. J. & 9 other authors (1994b). Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic-fusion to tetanus toxin fragment C in a live Aro attenuated vaccine. Proc Natl Acad Sci USA 91, 11261-11265.
25. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 259, 680-685.
26. Lewis, A. P. (1989). Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii. Mol Biochem Parasitol 36, 271-282.
27. Ling, I. T., Ogun, S. A. & Holder, A. A. (1994). Immunisation against malaria with a recombinant protein. Parasite Immunol 16, 63-67.
28. Ling, I. T., Ogun, S. A. & Holder, A. A. (1995). The combined epidermal growth factor-like modules of Plasmodium yoelii merozoite surface protein-1 are required for a protective immune response to the parasite. Parasite Immunol 17, 425-433.
29. Majarian, W. R., Daly, T. M., Weidanz, W. P. & Long, C. A. (1984). Passive immunization against murine malaria with an IgG3 monoclonal antibody. J Immunol 132, 3131-3137.
30. Miller, I. A., Chatfield, S., Dougan, G., Desilva, L., Joysey, H. S. & Hormaeche, C. E. (1989). Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typbimurium: use in identifying a role for aroD in attenuating virulent Salmonella strains. Mol Gen Genet 215, 312-316.
31. Pirson, P. J. & Perkins, M. E. (1985). Characterization with monoclonal antibodies of the surface antigen of Plasmodium falciparum merozoites. J Immunol 134, 1946-1951.
32. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
33. Siddiqui, W. A., Tam, L. Q., Kramer, K. J., Hui, G. S. N., Case, S. E., Yamaga, K. M., Chang, S. P., Chan, E. B. T. & Kan, S. C. (1987). Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci USA 84, 3014-3018.
34. Spencer Valero, L. M., Ogun, S. A., Fleck, S. L., Ling, I. T., Scott-Finnigan, T. J., Blackman, M. J. & Holder, A. A. (1998). Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein-1 suppresses parasitemia. Infect Immun 66, 3925-3930.
35. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets : procedure and some applications. Proc Natl Acad Sci USA 76, 4350-4354.